|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Subarachnoid Hemorrhage International Trialists (SAHIT) repository is a collection of randomized clinical trials, prospective observational studies, and hospital registries that was used to create a predictive model of unfavorable outcome/mortality following aneurysmal SAH.
|
30566611 |
2020 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
Rats exposed to subarachnoid haemorrhage were allocated to no treatment (SAH group) or TBN treatment by gastric gavage during the first 5 days after haemorrhage (SAH+TBN group).
|
30744667 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Abbreviations:</b> MMD: Moyamoya disease; STA: Superficial temporal artery; MCA: Middle cerebral artery; JAM: Japan Adult Moyamoya; ICH: Intracerebral hemorrhage; IVH: Intraventricular hemorrhage; SAH: Subarachnoid hemorrhage; CT: Computed tomography; TE: Total evacuation; PE: Partial evacuation; SMR: Light mass reduction; MR: Magnetic resonance; mRS: Modified Rankin scale; GCS: Glasgow Coma Scale; ICP: Intracranial pressure.
|
31608819 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
CSD = cortical spreading depolarization; IOS = intrinsic optical signal; IP = intraperitoneal; NMDA = N-methyl-d-aspartate; SAH = subarachnoid hemorrhage; SFB = surgical field blood.
|
30952117 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
Recent reviews of experimental subarachnoid hemorrhage ( SAH ) studies have brought to light the numerous neurobehavioral scoring systems that are used in preclinical SAH studies.
|
30971151 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
Of the 36,615 included patients, 81.6% had ischemic stroke and 18.4% had hemorrhagic stroke (15.5% intracerebral hemorrhage [ICH] and 2.8% subarachnoid hemorrhage [SAH]).
|
31313138 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
Twenty-four patients presented with subarachnoid hemorrhage [SAH] (32%) while forty nine patients with 52 aneurysms (68%) were unruptured.
|
30504576 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
ACA = anterior cerebral artery; ACoA = anterior communicating artery; FpA = frontopolar artery; ICG = indocyanine green; mRS = modified Rankin Scale; OfA = orbitofrontal artery; RAH = recurrent artery of Heubner; SAH = subarachnoid hemorrhage.
|
30952121 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Assessments in 24 h after SAH showed that treatment with 70 mg/kg Allicin in 30 min after SAH significantly restrained the expression of cleaved caspase-3, mitigated the severity of neuronal degeneration, decreased the proportion of apoptotic neurons and the elevated MDA levels, and increased the suppressed GSH and SOD levels.
|
30773476 |
2019 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
The clinical course of NA-SAH AB blood type patients shows similar severity as of aneurysmal subarachnoid hemorrhage.
|
29455413 |
2018 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
On univariate analysis, patients with Marfan syndrome were more likely to have a primary or secondary diagnosis of hemorrhagic stroke (0.5% versus 0.3%, odds ratio [OR] = 1.56, 95% confidence interval [CI] = 1.06-2.29, P = 0.02) as well as intracranial hemorrhage (subarachnoid hemorrhage [SAH] and hemorrhagic stroke) (0.3% versus 0.2%, OR = 1.72, 95% CI = 1.05-2.82, P = 0.03).
|
29030048 |
2018 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Ottawa SAH search algorithms: protocol for a multi- centre validation study of primary subarachnoid hemorrhage prediction models using health administrative data (the SAHepi prediction study protocol).
|
30219029 |
2018 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
If the types of stroke (any stroke, LVO, intracranial hemorrhage [ICH], and subarachnoid hemorrhage [SAH]) were to be predicted at the prehospital stage, better access to appropriate interventions would be possible.
|
30002147 |
2018 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
A post-ETV shunt was implanted in 1 patient (massive subarachnoid hemorrhage [SAH]) with final GOS score of 5.
|
29408347 |
2018 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
In patients with SAH, there is a significant increase in albumin oxidation, and albumin acts as a pro-oxidant; this promotes oxidative stress and inflammation in SAH patients through activation of neutrophils.(Hepatology 2017;65:631-646).
|
27775820 |
2017 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
There were 1,611 cases of ICB (n = 743 for intracerebral hemorrhage [ICH], n = 483 for subdural hematoma [SDH], and n = 385 for subarachnoid hemorrhage [SAH]).
|
29093065 |
2017 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
CONCLUSIONS The findings indicate that temporal miRNA profiling can detect differences between CSF from aneurysmal SAH and non-SAH patients.
|
27128592 |
2017 |
|
Subarachnoid Hemorrhage
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The results of the prior validation study assessing the accuracy of coding of stroke diagnoses in the NRHOSP were applied, and we calculated (1) the overall incidence of hospitalized stroke and (2) the incidence rates of hospitalized stroke for the three main stroke types: cerebral infarction (International Classification of Diseases Tenth Revision, CI I63), subarachnoid hemorrhage (SAH I60), and intracerebral hemorrhage (ICH I61).
|
27955808 |
2017 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the early emergent phase (first hours from injury), depending on intracranial pathology, BP manipulation aims to: 1) limit the progression of parenchymal hematomas or hemorrhagic transformation (in patients with ischemic/hemorrhagic stroke and aneurysmal subarachnoid hemorrhage [SAH]), and 2) attenuate hypoperfusion and secondary cerebral ischemic insults (in patients with traumatic brain injury [TBI]).
|
27982555 |
2017 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
Here we report the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I peptides with SAH (S-adenosylhomocysteine).
|
27474439 |
2016 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
Subarachnoid hemorrhage from sIA (sIA-SAH) is a devastating form of stroke.
|
24497844 |
2014 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
The outcome of subarachnoid hemorrhage in patients with familial occurrence of subarachnoid hemorrhage (familial SAH) is an important but neglected factor in balancing the risks of screening for asymptomatic aneurysms and repairing these in unaffected members of such families.
|
7762046 |
1995 |
|
Subarachnoid Hemorrhage
|
0.100 |
Biomarker
|
disease |
BEFREE |
The frequencies of the HLA-A, -B and -DR were determined in a group of 59 transplant donors who died from subarachnoid haemorrhage within three days following the rupture of intracranial aneurysm (the SAH group) and compared with those of a control group consisting of 389 donors who died from other causes.
|
1615764 |
1992 |